





Int. J. Environ. Res. Public Health 2021, 18, 12861. https://doi.org/10.3390/ijerph182312861 www.mdpi.com/journal/ijerph 
Systematic Review 
Effectiveness of Pre-Hospital Tourniquet in Emergency  
Patients with Major Trauma and Uncontrolled Haemorrhage:  
A Systematic Review and Meta-Analysis 
Roberto Latina 1,2,†, Laura Iacorossi 1,3,†, Alice Josephine Fauci 1,†, Annalisa Biffi 4, Greta Castellini 5,  
Daniela Coclite 1, Daniela D’Angelo 1, Silvia Gianola 5, Veronica Mari 1, Antonello Napoletano 1,*,‡, Gloria Porcu 4, 
Matteo Ruggeri 6, Primiano Iannone 1,§, Osvaldo Chiara 7,§ and on behalf of INIH—Major Trauma ‖ 
1 National Centre for Clinical Excellence Healthcare Quality and Safety, Istituto Superiore di Sanità, Via 
Giano della Bella 34, 00162 Rome, Italy; roberto.latina@unipa.it (R.L.); laura.iacorossi@gmail.com (L.I.);  
alice.fauci@iss.it (A.J.F.); daniela.coclite@iss.it (D.C.); daniela.dangelo@iss.it (D.D.);  
veronica.mari@iss.it (V.M.); primiano.iannone@iss.it (P.I.) 
2 Department of Health Promotion Science, Maternal and Infant Care, Internal Medicine and Medical  
Specialities, University of Palermo, Piazza delle Cliniche 2, 90127 Palermo, Italy 
3 IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Roma, Italy 
4 Laboratory of Healthcare Research and Pharmacoepidemiology, Department of Statistics and Quantitative 
Methods, University of Milano-Bicocca, Piazza dell’Ateneo Nuovo 1, 20126 Milan, Italy;  
annalisa.biffi@unimib.it (A.B.); gloria.porcu@unimib.it (G.P.) 
5 Unit of Clinical Epidemiology, IRCCS Istituto Ortopedico Galeazzi, Via Riccardo Galeazzi 4, 20161 Milan, 
Italy; greta.castellini@grupposandonato.it (G.C.); silvia.gianola@grupposandonato.it (S.G.) 
6 National Centre for Health Technology Assessment, Istituto Superiore di Sanità, Via Giano della Bella 34, 
00162 Rome, Italy; matteo.ruggeri@iss.it 
7 General Surgery and Trauma Team, ASST Grande Ospedale Metropolitano Niguarda, University of Milan, 
Piazza Ospedale Maggiore 3, 20162 Milan, Italy; osvaldo.chiara@unimi.it 
* Correspondence: antonello.napoletano@iss.it; Tel.: +39-0649906720 or +39-3395625998 
† Co-first authors. 
‡ Current Address: Centro Nazionale per l’Eccellenza Clinica, Qualità e Sicurezza delle Cure (CNEC), Istituto 
Superiore di Sanità, Via Giano della Bella, 34, 00162 Rome, Italy. 
§ Co-last authors. 
‖ Membership of the Italian National Institute of Health Guideline Working Group on Major Trauma is  
provided in the Acknowledgments. 
Abstract: Trauma is one of the leading causes of uncontrolled haemorrhage, death, and disability. 
Use of a tourniquet can be considered an optimal anti-haemorrhagic resource, in pre-hospital and 
emergency settings, and its lifesaving effect is clinically contradictory. This review aims to assess 
the clinical efficacy of the tourniquet in the emergency pre-hospital care setting for the management 
of haemorrhage. We conducted the systematic review following the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses, the PRISMA statement. We searched the following elec-
tronic databases: EMBASE, MEDLINE, and Cochrane-CENTRAL. All studies included were ap-
praised for risk of bias. Prevalent primary outcomes were mortality and use of blood products. Sec-
ondary outcomes were related to adverse effects. The quality of evidence was assessed using the 
Grading of Recommendations Assessment, Development and Evaluation approach (GRADE). Four 
studies were involved (1762 trauma patients). The adjusted odds ratio (aOR) of 0.47 (95% confidence 
Interval (CI) 0.19–1.16; three studies; 377 patients) for overall mortality estimates did not give a clear 
indication of the benefits of emergency pre-hospital tourniquets (PH-TQ) versus no pre-hospital 
tourniquet (NO PH-TQ) placement. The adjusted mean difference for blood product use was −3.28 
(95% CI −11.22, 4.66) for packed red blood cells (pRBC) and −4.80 (95% CI −5.61, −3.99) for plasma, 
respectively. The certainty of evidence was downgraded to very low for all outcomes. Our results 
suggest an unclear effect of emergency pre-hospital tourniquet placement on overall mortality and 
blood product use. However, this systematic review highlights the availability of only observational 
studies and the absence of high quality RCTs assessing the efficacy of PH-TQs. Randomized con-
trolled trials are needed. 
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1. Introduction 
Every year, the lives of about 1,35 million people are cut short as a result of trauma 
caused by road traffic crashes, and between 20 and 50 million people worldwide suffer 
non-fatal injuries [1], with many incurring a disability [2]. Uncontrolled bleeding is the 
leading cause of death in 34% of trauma patients. Haemorrhage is one of the major causes 
of potentially preventable deaths in both civilian and military contexts [3]. The Italian Na-
tional Institute for Statistics recorded a total of 172,183 traumas in 2019 [4], which, accord-
ing to the Multi-Regional Serious Trauma Intra-Hospital Centre [5], was prevalent in the 
male population (75.7%), and 65.4% (n = 4385) required intensive care unit (ICU) hospital-
ization with a mean stay of 7.3 days (standard deviation = ±14.6), a fatal outcome of 27.5%, 
and 17.4% of patients requiring transfusions in the emergency room [6]. Bleeding control 
in major trauma is a clinical priority that can be achieved through either direct compres-
sion or the use of mechanical or pneumatic tourniquets (TQ). Direct pressure is the first 
and simplest step. TQs can be applied if direct pressure on the bleeding area is not suffi-
cient to control the bleeding [7] and when direct pressure is not a feasible option. Direct 
pressure should be maintained by health care personnel, which is sometimes insufficient 
in number. Use of a TQ can be considered an optimal anti-haemorrhagic resource in an 
emergency setting, and its lifesaving effect has become more apparent [8]. The use and 
effectiveness of mechanical or pneumatic TQs appears to be associated with effective con-
trol of bleeding and lower mortality rates from bleeding [9]. This is why the Hartford 
Consensus Conference [10] encourages their widespread use among the civilian popula-
tion for the early control of haemorrhage in the extremities (upper and lower limbs) when 
direct manual compression is ineffective or unfeasible. In the literature, the efficacy of TQ 
application for the management of bleeding in the pre-hospital phase in patients with ma-
jor trauma is supported by relatively low, often contradictory evidence, or is even not 
recommended for use in the civilian context [8]. In particular, it remains an open question 
whether when used in the pre-hospital setting, it leads to better survival and a reduced 
need for blood, or blood component, transfusions. This systematic review aims to sum-
marize current knowledge on the clinical efficacy of pre-hospital TQ, which has been used 
as a framework to support the development of Italian guidelines for pre-hospital emer-
gency treatment of major trauma (MT) in civilian settings. 
2. Materials and Methods 
We conducted a systematic review to support the major trauma integrated manage-
ment guideline panel of the Italian National Institute of Health (NIH) in formulating rec-
ommendations [11]. Following the GRADE-ADOPOLMENT methodology [12], and in ac-
cordance with the standards defined by the NIH [13], the multidisciplinary panel decided 
to apply a structured and systematic updating and adaptation process of their recommen-
dations from the National Institute for Clinical Excellence (NICE) guideline NG39 on pre-
hospital application of TQs [14]. We conducted the systematic review following the Pre-
ferred Reporting Items for Systematic Reviews and Meta-Analyses, the PRISMA state-
ment [15]. Study protocol has been stored at the following link: https://osf.io/n526s/ (ac-
cessed date 29 November 2021). The research question for this systematic review was: “Is 
the use of pneumatic or mechanical tourniquets both clinically effective and cost-effective 
in improving outcomes in major trauma patients with haemorrhage?”. 
2.1. Inclusion Criteria 
We included randomized controlled trials (RCT); cohort studies with adjusted results 
for key confounders (e.g., injury severity, age, depth of shock, degree of head injury) or 
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matched at baseline for these if no RCT was available and/or observational studies. Eligi-
ble studies should meet the following criteria: (1) population: children, young people and 
adults who have experienced a traumatic limb injury; (2) intervention: pneumatic and 
mechanical TQ use; (3) comparison: no TQ use; and (4) setting: pre-hospital. Studies in-
cluding patients requiring massive transfusion resulting from civilian settings were in-
cluded. 
2.2. Outcome Measures and Follow-Up Assessment 
The primary outcome measures selected for the analyses were: (i) 24 h-mortality, 30-
day to 12-months mortality; (ii) volume of infused blood components; and (iii) health-
related quality of life (e.g., Glasgow Coma Scale [GCS] score at discharge). The secondary 
outcomes referring to adverse effects were related: (iv) amputation; (v) nervous system 
disorder-paralysis; (vi) renal failure; and (vii) haemorrhage. 
2.3. Search Strategy 
We searched the following electronic databases: MEDLINE (Pub-Med), EMBASE, 
Cochrane Central Register of Controlled Trials (CENTRAL) with language restriction 
(English, Italian, Spanish, French, German), using and updating (from March 2015 up to 
February 2020) the search strategy of the high quality clinical guideline of NICE on MT 
[14], reported in Supplementary Materials S1. We checked the reference lists of all studies 
included and of all the systematic reviews identified during the search process. We also 
searched for ongoing trials: ClinicalTrials.gov. 
2.4. Study Selection and Data Extraction 
Two independent authors (SG, GC) screened titles and abstracts according to the 
search strategy. Following the first phase, they independently assessed the full text of all 
potentially relevant studies for inclusion in this review. Any disagreement was resolved 
through discussion with a third author (OC). Then, using a standardized data collection 
form, the following information was extracted from the included studies: (i) study char-
acteristics: study design, setting, countries and settings, funding; (ii) participants’ charac-
teristics, sample size and type of trauma; and (iii) intervention type and outcomes. We 
contacted authors if the reported data were not sufficiently detailed or incomplete. Any 
discrepancy was resolved by consensus, or with the help of a third independent author 
(AB). The bibliographies of retrieved papers were also evaluated to identify other relevant 
articles to be included. Reasons for exclusion are reported in Figure 1. 




Figure 1. Flow chart of study selection. 
2.5. Internal Validity 
The internal validity of non-randomized studies was assessed using the Newcastle–
Ottawa Scale [16]. The following domains were appraised: selection, comparability, and 
outcome. Thresholds for converting the Newcastle–Ottawa Scale to AHRQ standards 
(good, fair, and poor) were adapted. Two reviewers (SG, GC) independently evaluated 
the methodological quality of the included studies, and any disagreement was resolved 
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2.6. Data Synthesis 
Whenever possible, meta-analyses were conducted to combine the outcome data us-
ing the DerSimonian and Kacker random effects model [17], which takes into account both 
the sampling variance within the studies and the variation in the underlying effect across 
studies due to the different populations and study designs. To assess the statistical heter-
ogeneity across studies, we applied Cochran’s Q statistics and calculated the I2 test [18], 
using the following interpretation of the value of I2: 0 to 50 = low; 50 to 80 = moderate and 
worthy of investigation; 80 to100 = severe and worthy of understanding; 95 to 100 = ag-
gregate with major caution (Julian Higgins, personal communication). The analyses were 
performed using RevMan Version 5.4. The treatment effects for continuous outcomes 
were summarized as mean difference (MD) or standardized mean difference (SMD) when 
different outcome measurements were reported; the treatment effects for dichotomized 
outcomes were evaluated using the odds ratio (OR). When adjustments or propensity 
scores for each of the outcomes were available, we pooled them as adjusted odds ratios 
(aORs). 
2.7. Quality of Evidence 
The quality of evidence of each outcome was judged by evaluating five dimensions 
(risk of bias, consistency of effect, imprecision, indirectness, and publication bias) using 
the Grading of Recommendations Assessment Development and Evaluation (GRADE) 
approach [19]. The evidence was downgraded from ‘high quality’ by one level if serious 
limitations were found for each of the five dimensions, or by two levels, if very serious 
limitations were found. We presented a summary of findings describing the treatment 
effects, the quality of evidence, and the reasons for the limitations. 
3. Results 
A total of 395 records were screened. From the updated search, four observational 
studies [20–23] were included (Figure 1). For details on excluded studies, see Supplemen-
tary Materials S2. 
3.1. General Characteristics 
None of the included studies were RCTs or a systematic review of RCTs. The four 
included studies were conducted in the U.S. and were retrospective cohort studies report-
ing data from trauma registers [20–23] and from computerized clinical data records [23]. 
The included studies allowed for the following comparisons: (1) pre-hospital tourniquet 
(PH-TQ) versus (vs.) tourniquet (NPH-TQ) [20,21,23]; and (2) pre-hospital tourniquet 
(TQ) vs. trauma centre-tourniquet (TC-TQ) [22]. The studies reviewed involved a total of 
1762 trauma patients, 1455 of whom to compare PH-TQ application vs. NPH-TQ 
[20,21,23], and 306 to evaluate PH-TQ vs. TC-TQ application [22]. General characteristics 
of the studies are reported in Table 1. Demographic and clinical characteristics of obser-
vational studies are described in Tables 2–4. 
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Table 1. General characteristics. 
Study 
(First Author, Year) 
Country 
(State) 







McNickle et al. (2019)  
Retrospective 
cohort study 
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Table 2. Demographic and clinical characteristics of observational studies. 
Study 
Sample Age (years) Sex (Male) ISS Extremity AIS GCS HR SBP 
N Mean (SE) N(%) Mean (SE) Mean (SE) Median (IRQ Range) Mean (SE) Mean (SE) 
PH-T NPH-T PH-T NPH-T PH-T NPH-T PH-T NPH-T PH-T NPH-T PH-T NPH-T PH-T NPH-T PH-T NPH-T 
McNickleet 
al.,2019 
69 69 35 (±1.5)  36.3 (±1.6) 56(88.9) 53(84.1) 13.1 (±0.8) 12.3 (±0.9) 3.2 (±0.1) 3 (±0.1) - - 110 (±4) 100 (±3) 126 (±4) 130 (±3) 
Smith et al., 2018 127 77 31.3 (±0.7) 31.2 (±1.6) 111(87.4) 68(88.3) 9 (±0.5) 10.1 (±0.6) 2.8 (±0.2) 2.7(±0.2) - - 100 (±2) 104 (±5) 114 (±2) 98 (±4) 
Scerbo et al., 2017 * 252 29 33 (25.46) (1) 34 (24.50) (1) 212(84.1) 27(93.1) 9(5.17) (1) 20 (9.27) (1) 3(2.3) (1) 3(3.4) (1) 15 (14.15) (1) 14 (3.15) (1) 100(84.120) (1) 122(87.135) (1) 119 (92.139) (1) 100 (83.113) (1) 
Teixeira et al., 2018 181 845 34.4 (±1.1) (2) 35.9(±0.5) (2) 157(86.7) 708(83.7) 13.2 (±0.8) (2) 11.3(±0.3) (2) 36(180) (3) 77(9.1) (3) 28(178) (4) 91(838) (4) 105.9 (±2.1) (2) 92.6 (±0.9) (2) 125.3 (±7) (2) 121.7 (±1.2) (2) 
PH-T: pre-hospital tourniquet; NPH-T: non pre-hospital tourniquet; ISS: Injury Severity Score; AIS: Abbreviated Injury Scale; GCS: Glasgow Coma Scale; HR: Heart Rate, SBP: systolic 
blood pressure; (1) expressed as median (IRQ range); (2) expressed as mean (SD); (3) expressed as N (extremity AIS ≥4); and (4) expressed as N (GCS < 8); * Scerbo et al. (2017) compared 
pre-hospital tourniquet vs. trauma centre tourniquet. 
Table 3. Outcome data for the comparisons of mortality. 
Study 








% Sample N Events % 
McNickle et al. (2019) 69 0 0 69 2 2.9 NS NR 
Variable matching by patient demographics and injured 
artery, ISS, and mechanism of injury. 
Smith et al. (2018) 127 9 7.1 77 10 13 0.21 NR 
Variable matching by patient demographics and injury se-
verity. 
Teixeira et al. (2018) 181 7 3.9 845 44 5.2 0.45 NR 
ISS, presence of associated severe head or torso injury, 
presence of major vascular injury, and traumatic amputa-
tion. 
Study 





Sample N events % Sample N events % 
Scerbo et al. (2017) 252 13 5.2 29 4 13.8 0.07 NR Data not adjusted 
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Table 4. Transfusion of blood products. 
(1) Packed Red Blood Cells Transfusion (pRBC) 
Studies 





Sample Mean (SD) Sample Mean (SD) 
McNickle et al. (2019) 69 3.5(0.5) 69 2.7(0.8) NS 
within first 24 
h 
Variable matching by patient demographics and injured artery, and mechanism of 
injury. 
Teixeira et al. (2018) 181 5.0 (8.6) 845 3.9 (14.5) 0.380 
within first 24 
h 
Variable adjusted by age, sex, mechanism of injury, hypotension on admission, 
GCS, ISS, presence of associated severe head or torso injury, presence of major 
vascular injury, and traumatic amputation. 
Smith et al. (2018) 127 2.0(0.1) (1) 77 9.3(0.6) (1) <0.001 
within first 24 
h 
Variable matching by patient demographics and injury severity. 
Study 





Sample Median (IQR) Sample Median (IQR) 
Scerbo et al. (2017) 252 3(1.6) 29 4(2.9) 0.10 
within first 24 
h 
 
(2) Platelets transfusion 
Study 





Sample Mean (SD) Sample Mean (SD) 
Teixeira et al. (2018) 181 0.8(2.2) 845 0.5(2.4) 0.237 
within first 24 
h 
Variable adjusted by age, sex, mechanism of injury, hypotension on admission, 
GCS, ISS, presence of associated severe head or torso injury, presence of major 
vascular injury, and traumatic amputation. 
Study 





Sample Median (IQR) Sample Median (IQR) 
Scerbo et al. (2017) 252 1(1.3) 29 2(1.6) 0.11 
within first 24 
h 
 
(3) Plasma transfusion 
Studies 





Sample Mean (SD) Sample Mean (SD) 
Teixeira et al. (2018) 181 2.8 (6.8) 845 1.8(4.7) 0.030 
within first 24 
h 
Variable adjusted by age, sex, mechanism of injury, hypotension on admission, 
GCS, ISS, presence of associated severe head or torso injury, presence of major 
vascular injury, and traumatic amputation.. 
Smith et al. (2018) 127 1.4(0.1) (1) 77 6.2(0.4) (1) <0.001 
within first 24 
h 
Variable matching for patient demographics and injury severity 
Study 





Sample Median (IQR) Sample Median (IQR) 
Scerbo et al. (2017) 252 3(2.5) 29 5(3, 10) <0.01 
within first 24 
h 
 
(1) expressed as mean (standard error); GCS: Glasgow Coma Scale; ISS: Injury Severity Score; NS: not statistically significant; IQR: interquartile range. 
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3.2. Primary Outcomes 
3.2.1. Mortality at 24 h, 30 Days, and 12 Months 
Three studies [20,21,23] compared PH-TQ intervention vs. NPH-TQ intervention and 
reported adjusted results on overall mortality (Table 3). Quantitative analyses were there-
fore performed on these only (Figure 2). One study [22], reported adjusted results on mor-
tality due to trauma haemorrhage comparing PH-TQ vs. TC-TQ showing an odds ratio of 
0.22 [CI 95% 0.06–0.80], and standard error = 0.66) [22] (Figure 3). The authors in [20,21,23] 
compared PH-TQ vs. non-intervention, or with intervention at the trauma centre, in terms 
of mortality caused by haemorrhage [22]. One study [20] was reported without an esti-
mate of the effect, as the published data were not clearly reported. 
Despite the differences between the observational studies included, the forest plots 
(Figures 2 and 3) fairly consistently showed a lower mortality risk with pre-hospital ap-
plication of the PH-TQ compared to NPH-TQ or TC-TQ. The analysis showed no differ-
ences between the experimental group that received TQ and the controls. 
 
Figure 2. Adjusted odds ratio for overall mortality of pre-hospital-TQ vs. no pre-hospital-TQ. 
3.2.2. Packed of Infused Blood Components 
Three different types of blood components were analysed: (a) pRBC transfusion [20–
23]; (b) Platelets [20,22] (Table 4); and (c) Plasma [20,22,23]. As shown in Table 4, Smith et 
al. (2019) provides an adjusted estimate showing how the application of the tourniquet 
reduces the number of transfused plasma units, whereas Texeira et al. (2018) did not pro-
vide clear indications about the benefits of applying the tourniquet on pRBC and plasma 
requirements (Figure 3). 
 
Figure 3. Adjusted odds ratios for mortality due to haemorrhage of PH-T vs. NO PH-T. 
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3.2.3. Length of Stay (LOS) in ICU 
LOS in ICU in two study groups, PH-TQ group compared to the NPH-TQ and PH-
TQ group compared to TC-TQ is reported as days in ICU [3] and 30-day ICU free days 
[21]. In the study by [22], the ICU LOS (mean days) was 3.9 (standard deviation (SD) = 
±7.2 days) in the PH-TQ group vs. 2.9 (SD = ±6.5 days) (p= 0.064), OR (95% CI)= −1.01(−2.09 
to 0.06) in the control group. In the study by [22], the ICU length of stay (median days), 
using PH-TQ group compared to the trauma centre tourniquet was 0 (interquartile range 
(IQR) = 0.2) vs. 2 (IQR= 0.5), p< 0.01. In both studies, the time point is not defined. The 
study by [22] showed no clear difference in ICU LOS (days) between the PH-TQ group 
compared to NPH-TQ, 25.8 (SD = ±0.7 days) vs. 26.7(SD = ±0.6) (p-value not significant), 
with a time point of 30 days (mean difference = −090[CI 95% = −2.71–0.91]). 
3.2.4. Health-Related Quality of Life 
No study has reported on the outcomes of interest. 
3.3. Secondary Outcomes 
Four different secondary outcomes in terms of adverse events (Figure 4) reported 
from the following studies were classified: 
Amputation: (i) Not reported whether early/late application: the study by [22] reports 
unadjusted values; (ii) initial application: the study by [21] shows how the application of 
the tourniquet increases the risk of initial amputation; and (iii) late application: three arti-
cles reported data on delayed placement [20,21,23], which provide an unclear estimate on 
the adjustments and are therefore not meta-analysable. 
Nervous system disorders-paralysis: Only one article reported the data on nerve 
palsy [23], showing no significant differences between PH-TQ vs. NPH-TQ application. 
 
Figure 4. Adjusted odds ratio for adverse events of pre-hospital-TQ versus no pre-hospital-TQ. 
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Renal failure: One article reported data on renal failure showing no significant dif-
ferences between PH-TQ vs. NPH-TQ application [21]. 
Haemorrhage: One article reported data on this adverse event showing [23], lower 
risk of performing procedures for the control of bleeding (due to a lower probability of 
bleeding) with the application of a tourniquet. 
3.4. Internal Validity 
Three studies were judged to be of good quality and one of fair quality (Supplemen-
tary Materials S3). Overall, studies were affected by bias in selection and outcome do-
mains. 
3.5. Quality of Evidence 
For all of the aforementioned outcomes, the certainty of evidence was downgraded 
to very low due to serious risk of bias, indirectness, and imprecision of the estimates (Sup-
plementary Materials S4). For the remaining outcomes (time to definitive control of haem-
orrhage and patient-reported outcomes), the quality of evidence was not assessed due to 
the absence of data. 
4. Discussion 
This systematic review highlights the efficacy of the emergency application of PH-
TQ in civilian trauma. TQ application is on the rise in the USA, and this trend seems to be 
mainly in large cities or urban areas with well-developed trauma systems. To our 
knowledge, this study is the first to propose a meta-analysis of the results of the four ret-
rospective cohort studies included. 
4.1. Use of Tourniquet and Mortality 
The studies reviewed about 1800 trauma patients, one third of whom received PH-
TQ application. Our meta-analysis showed that use of PH-TQ did not appear to signifi-
cantly influence mortality (aOR = 0.47, 95% CI 0.19–1.16; p = 0.55). The evidence (GRADE) 
on overall causes of mortality and mortality caused by haemorrhage was ranked as very 
low-certainty (critical). Our results are concordant with Scerbo et al. (2016) [24] (6% 
vs.12%, p = 0.61). One recent review of ten studies failed to show a statistically significant 
difference in all-cause mortality where a tourniquet had been used compared with direct 
pressure alone [6]. Additionally, there was no difference in mortality outcomes in another 
study where tourniquets were applied in the presence or absence of shock [25]. Unsur-
prisingly, the early placement of a TQ in military casualty, before the onset of shock, was 
associated with a decreased risk of mortality [26]. Vascular injuries of the limbs in the 
military setting are common and this is probably the reason for the significant effect on 
survival. It is unclear whether the mortality rate in our population of reference is partially 
attributable to tourniquet use. 
4.2. Blood Products Use and LOS in ICU 
The aOR by meta-analysis for blood product use shows that PH-TQ use is significant 
for plasma (p < 0.001) and not for pRBC. Regarding the use of RBC in the first 24 h [23], it 
showed a reduction in the use of this type of blood component. Regarding plasma only, 
[22] demonstrated that blood transfusions within the first hour and mortality from haem-
orrhagic shock decreased among patients with PH-TQ use. However, compared to PH-
TQ, patients with TC-TQ had a higher rate of transfusion within the first hour of arrival 
(p = 0.02). Moreover, Teixeira et al. [20] also explained that the tourniquet patients were 
more likely to require massive plasma transfusion, to present a higher Injury Severity 
Score (ISS) and Abbreviated Injury Scale (AIS) score, and to be in shock. 
Regarding LOS in ICU, [22] provided an unclear estimate of the adjustment and 
therefore cannot be represented, and in [21], at 30-day ICU free days, no clear difference 
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was perceptible between the two groups. Several data regarding TQ application should 
be interpreted carefully. A precise indication and definition of TQ exposure time have 
been rarely specified, as described in [6]. This may impact on the primary and secondary 
outcomes. 
4.3. Secondary Outcomes 
Moreover, unadjusted values on amputation can provide misleading information, 
and are therefore not meta-analysable; they do not provide a clear indication regarding 
the benefits of applying a tourniquet. Concerning haemorrhage, only a single article [23] 
indicates a lower risk of performing procedures to control bleeding due to a lower prob-
ability of bleeding when a tourniquet is applied, which describes aOR for adverse events 
of PH-TQ vs. NPH-TQ. 
4.4. The Quality of Evidence 
Regarding internal validity, although three studies were judged to be of good quality 
and one of fair quality (Supplementary Materials S3), overall, studies were affected by 
bias in selection and outcome domains. Using GRADE methodology, the quality of evi-
dence obtained from the observational studies for all of the aforementioned outcomes was 
downgraded to very low due to a serious risk of bias, indirectness, and imprecision of the 
estimates (Supplementary Materials S4). 
4.5. Implication for Clinical Practice 
TQs were used in various situations and involved quite homogeneous types of inju-
ries and locations; they were mainly used for extremity injuries. As described in [6], a 
precise indication and definition of TQ exposure time was rarely specified. Only one study 
defined the indications for TQ use as cases of extremity vascular injury [22]. Moreover, 
tourniquets should only be used to control extremity haemorrhage if direct pressure is not 
adequate or possible, for example, in the case of multiple victims or injuries, inaccessible 
wounds, or when nurses and medical staff are working together to achieve the resuscita-
tion and stabilization of critical patients. Although not significantly, a trend toward re-
duction in mortality with PH-TQ was shown in our study. It is common sense that proxi-
mal TQ is able to stop ongoing haemorrhage of a limb and that the application in the field 
is a very simple action that reduces blood loss and improves haemodynamics. Moreover, 
after TQ application, the health care personnel are available for other manoeuvres while 
limb bleeding is controlled. TQ application should only be used if direct pressure is not 
adequate or possible. The available literature suggests that commercial tourniquets are 
superior to the application of direct manual pressure or haemostatic dressings for life-
threatening limb bleeding [27]. We found that patients who received a PH-TQ were 
mostly men (range age 30–36 years), and that tourniquets were mainly applied by health 
staff, as described in a recent review [6]. The pre-hospital advanced emergency staff such 
as nurses and physicians (Italy does not have paramedics) should be familiar with a tour-
niquet that has been proven to be effective. There is evidence that staff trained to use PH-
TQ are more likely to do so and have fewer fears of complications in comparison with 
untrained staff [28]. Requiring pre-hospital trauma life support certification at regular in-
tervals should help with skill decline and continued education as this course is updated 
with the current evidence. Although in the majority of cases external haemorrhage will be 
controlled by employing a stepwise approach, TQ use could be considered as a potential 
anti-haemorrhagic resource, and its life-saving effect may become more apparent [8]. 
The results of this meta-analysis allowed us to determine a recommendation on the 
use of the tourniquet for trauma in a pre-hospital setting. The guideline becomes a coun-
try’s strongest tool for homogenizing the clinical behaviour of healthcare practitioners and 
monitoring adherence to recommendations.  
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5. Limits and Strength 
This systematic review highlights the absence of high quality RCTs assessing the ef-
ficacy of PH-TQs. Quantitative analyses were performed on only three retrospective ob-
servational studies reporting adjusted results. Moreover, most of the included studies 
were affected by bias in selection and outcome domains, and the certainty of the evidence 
for all the assessed outcomes was judged as ‘very low’ due to a serious risk of bias, indi-
rectness, and imprecision of the estimates. Finally, we have our concerns whether the re-
sults of the four included studies can all be combined into one conclusion, since all afore-
mentioned arguments result in heterogeneous study populations. Despite these limita-
tions, this study presented points of strength: the internal validity of the included studies, 
which was assessed using the Newcastle–Ottawa Scale for observational studies, was ro-
bust and largely acknowledged. 
6. Conclusions 
Based on observational data, our analysis suggests that the effectiveness of the early 
application of PH-TQ on the mortality rate in our population of reference, and on different 
blood components used, is unclear. Though this systematic review was unable to identify 
high quality evidence, the available evidence could be used by experts for formulating 
judgments and recommendations though a structured and transparent process such as 
the GRADE-ADOLOPMENT [12]. Adoption of a multi-centre registry with standardised 
prospective data collection, specific to tourniquet use, can serve to improve the trauma 
community’s understanding of the safety and effectiveness of tourniquet use in civilian 
trauma settings. Future studies, preferably randomised controlled trials, should be carried 
out in order to confirm preliminary results determined in observational studies. 
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